These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 22917793)

  • 1. Stent for Life: an initiative reflecting the spirit of the European Community.
    Tajani A
    EuroIntervention; 2012 Aug; 8 Suppl P():P6-7. PubMed ID: 22917793
    [No Abstract]   [Full Text] [Related]  

  • 2. Stent for Life: how this initiative began?
    Widimsky P; Wijns W; Kaifoszova Z
    EuroIntervention; 2012 Aug; 8 Suppl P():P8-10. PubMed ID: 22917797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variable penetration of primary angioplasty in Europe--what determines the implementation rate?
    Kristensen SD; Laut KG; Kaifoszova Z; Widimsky P
    EuroIntervention; 2012 Aug; 8 Suppl P():P18-26. PubMed ID: 22917786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stent for Life in France.
    Gilard M; Fajadet J; ; Belle L; Carrie D; Cottin Y; Ducasse JL; Dujardin JJ; Freysz M; Garot P; Goldstein P; Le Breton H; Lefèvre T; Savary D; Ta TH; Van Belle E
    EuroIntervention; 2012 Aug; 8 Suppl P():P77-9. PubMed ID: 22917796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stent for Life project: present situation in Turkey.
    Göktekin Ö; Ertaş G; Kervan Ü; Koç O; Kozan Ö
    EuroIntervention; 2012 Aug; 8 Suppl P():P133-5. PubMed ID: 22917785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COURAGE or FAME...? Who should have percutaneous coronary intervention in stable coronary artery disease?
    Fox KA
    Heart; 2013 Apr; 99(7):442-4. PubMed ID: 23086969
    [No Abstract]   [Full Text] [Related]  

  • 7. STEMI guidelines: from formulation to implementation.
    Di Mario C; Syrseloudis D; James S; Viceconte N; Wijns W
    EuroIntervention; 2012 Aug; 8 Suppl P():P11-7. PubMed ID: 22917781
    [No Abstract]   [Full Text] [Related]  

  • 8. Two-year outcomes after deployment of XIENCE V everolimus-eluting stents in patients undergoing percutaneous coronary intervention of bifurcation lesions: a report from the SPIRIT V single arm study.
    Džavík V; Kaul U; Guagliumi G; Chevalier B; Smits PC; Stuteville M; Li D; Sudhir K; Grube E
    Catheter Cardiovasc Interv; 2013 Sep; 82(3):E163-72. PubMed ID: 23225766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bare-metal stent versus drug-eluting stent in large coronary arteries: meta-analysis of randomized controlled trials.
    Geng DF; Meng Z; Yan HY; Nie RQ; Deng J; Wang JF
    Catheter Cardiovasc Interv; 2013 Jun; 81(7):1087-94. PubMed ID: 22899538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stent for Life Initiative--the Greek experience.
    Kanakakis J; Ntalianis A; Papaioannou G; Hourdaki S; Parharidis G
    EuroIntervention; 2012 Aug; 8 Suppl P():P116-20. PubMed ID: 22917782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Placement of Tryton Side Branch Stent only; a new treatment strategy for Medina 0,0,1 coronary bifurcation lesions.
    Grundeken MJ; Agostoni P; Lesiak M; Koch KT; Voskuil M; de Winter RJ; Wykrzykowska JJ; Stella PR
    Catheter Cardiovasc Interv; 2013 Oct; 82(4):E395-402. PubMed ID: 23554121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stent for Life Initiative placed at the forefront in Egypt 2011.
    Sobhy M; Sadaka M; Okasha N; Farag el S; Saleh A; Ismail H; El Seteiha M; Ragy H; Hameed MA; Mehanna R
    EuroIntervention; 2012 Aug; 8 Suppl P():P108-15. PubMed ID: 22917780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Six-month and one-year clinical outcomes after placement of a dedicated coronary bifurcation stent: a patient-level pooled analysis of eight registry studies.
    Grundeken MJ; Asgedom S; Damman P; Lesiak M; Norell MS; Garcia E; Bethencourt A; Woudstra P; Koch KT; Vis MM; Henriques JP; Onuma Y; Foley DP; Bartorelli AL; Stella PR; Tijssen JG; de Winter RJ; Wykrzykowska JJ
    EuroIntervention; 2013 Jun; 9(2):195-203. PubMed ID: 23360690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and effectiveness of drug-eluting stents versus bare-metal stents in elderly patients with small coronary vessel disease.
    Puymirat E; Mangiacapra F; Peace A; Ntarladimas Y; Conte M; Bartunek J; Vanderheyden M; Wijns W; de Bruyne B; Barbato E
    Arch Cardiovasc Dis; 2013 Nov; 106(11):554-61. PubMed ID: 24231052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Remote ischemic preconditioning improves outcome at 6 years after elective percutaneous coronary intervention: the CRISP stent trial long-term follow-up.
    Davies WR; Brown AJ; Watson W; McCormick LM; West NE; Dutka DP; Hoole SP
    Circ Cardiovasc Interv; 2013 Jun; 6(3):246-51. PubMed ID: 23696599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Everolimus-eluting stents and zotarolimus-eluting stents for percutaneous coronary interventions: two-year outcomes in New York State.
    Hannan EL; Zhong Y; Wu C; Walford G; Holmes DR; Jacobs AK; Stamato NJ; Venditti FJ; Sharma S; Fergus I; King SB
    Catheter Cardiovasc Interv; 2013 Jun; 81(7):1097-105. PubMed ID: 22707353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential long-term outcomes of zotarolimus-eluting stents compared with sirolimus-eluting and paclitaxel-eluting stents in diabetic and nondiabetic patients: two-year subgroup analysis of the ZEST randomized trial.
    Jang SJ; Park DW; Kim WJ; Kim YH; Yun SC; Kang SJ; Lee SW; Lee CW; Park SW; Park SJ
    Catheter Cardiovasc Interv; 2013 Jun; 81(7):1106-14. PubMed ID: 22899589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes in patients with renal impairment undergoing percutaneous coronary intervention and implantation of the Endeavor zotarolimus-eluting stent: 1- and 2-year data from the E-Five Registry.
    Rothman MT; Jain AK;
    Catheter Cardiovasc Interv; 2012 Nov; 80(6):885-92. PubMed ID: 22517785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Six-year clinical outcomes of first-generation drug-eluting stents: a propensity-matched analysis.
    Tarantini G; Barioli A; Facchin M; Frigo AC; Napodano M; Buja P; D'Amico G; Iliceto S; Isabella G
    Coron Artery Dis; 2013 Aug; 24(5):440-8. PubMed ID: 23695366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of everolimus-eluting stents versus paclitaxel-eluting stents in a diabetic population.
    Laynez A; Sardi G; Hauville C; Barbash IM; Pakala R; Torguson R; Xue Z; Satler LF; Pichard AD; Waksman R
    Catheter Cardiovasc Interv; 2013 Apr; 81(5):759-65. PubMed ID: 22488756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.